Vicapsys Life Sciences, Inc.
VICP
$1.77
$0.5039.37%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 13.56% | -15.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.41% | -11.01% | |||
| Operating Income | -9.41% | 11.01% | |||
| Income Before Tax | -23.88% | 41.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.88% | 41.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.88% | 41.88% | |||
| EBIT | -9.41% | 11.01% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -23.21% | 45.10% | |||
| Normalized Basic EPS | -22.86% | 25.53% | |||
| EPS Diluted | -23.21% | 45.10% | |||
| Normalized Diluted EPS | -22.86% | 25.53% | |||
| Average Basic Shares Outstanding | 0.41% | 6.60% | |||
| Average Diluted Shares Outstanding | 0.41% | 6.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||